Limitless X Inc. entered into a definitive share exchange agreement to acquire Bio Lab Naturals, Inc. (OTCPK:BLAB) in a reverse merger transaction for approximately $140 million on May 11, 2022. As part of the share exchange agreement, BLAB will issue 97 million shares to Limitless X shareholders at the close of the transaction. An additional 9 million shares will be issued to Limitless X shareholders pro-rata to their interests, which will result in those shareholders owning 90% of BLAB's outstanding shares six months post acquisition. Limitless X Inc. will go public as a result of this transaction. Following completion, Bio Lab Naturals will carry on its business and core operations, including Prime Time Live, Inc. Upon completing the proposed acquisition with Bio Lab Naturals, the combined entity will continue to trade publicly under the BLAB ticker symbol. Following the close, an application will be submitted to FINRA to obtain a new symbol. Closing of the acquisition is subject to usual terms and conditions. The transaction is subject to due diligence, Financing, BLAB will (i) have shares listed for trading on and shall be in good standing with OTCQB; (ii) endeavor to be DWAC and DTC eligible and other. Limitless expects the acquisition to close within the next 7 business days. As of May 13, 2022, the transaction is expected to close on or about May 20, 2022.

Ken Bart of Smith Eilers, PLLC acted as legal advisor to Bio Lab Naturals. Rob Cucher of Law Offices of Rob Cucher acted as legal advisor to Limitless.